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INTRODUCTION
Mucus in the human airway is very important for defense against invading pathogenic microorganisms, chemicals and particles. This defensive action of airway mucus is attributed to the physicochemical properties of mucins. Mucins are multimillion dalton glycoproteins present in the airway mucus and are produced by goblet cells in the surface epithelium as well as mucous cells in the submucosal gland. However, hypersecretion of airway mucus is one of the major symptoms associated with severe pulmonary diseases including asthma, chronic bronchitis, cystic fi brosis and bronchiectasis (Voynow and Rubin, 2009 ). There are two ways to remove excess mucus from the airway; 1) get rid of the mucus by physical means, ie, aspiration after dilution of mucus, and 2) suppression of secretion and/or production of mucus by pharmacological means. However, clinically, the physical method induces irritation of the airway luminal wall and simulates hypersecretion of mucus through a refl ex mechanism. Thus, the In this study, we investigated whether ambroxol signifi cantly affects secretion, production and gene expression of mucin from cultured airway epithelial cells. Confl uent primary rat tracheal surface epithelial (RTSE) cells were pretreated with adenosine triphosphate (ATP) for 5 min and then treated for 30 min with ambroxol to assess the effect on mucin secretion using ELISA. Additionally, confl uent NCI-H292 cells were pretreated with ambroxol for 30 min and then stimulated with EGF or PMA for 24 h. The MUC5AC mucin gene expression and mucin protein production were measured by RT-PCR and ELISA. The results were as follows: (1) ambroxol did not signifi cantly affect ATP-induced mucin secretion from cultured RTSE cells; (2) ambroxol inhibited the production of MUC5AC mucin protein induced by EGF and PMA in NCI-H292 cells; (3) ambroxol also inhibited the expression of MUC5AC mucin gene induced by EGF and PMA in NCI-H292 cells. This result suggests that ambroxol can inhibit the production and gene expression of MUC5AC mucin, by directly acting on human airway epithelial cells.
Abstract
pharmacological means to inhibit mucin secretion and/or production has become an important approach to regulate the hypersecretion of airway mucus (Mutschler and Derendorf, 1995) . Secretion of airway mucin is generally stimulated by various agents. Whereas glucocorticoids inhibit the hypersecretion of airway mucins (Mutschler and Derendorf, 1995; Lee et al., 2002) , they have various limitations in their application to pharmacotherapy of human diseases involving airway mucus hypersecretion. An alternative approach for regulation of airway mucus hypersecretion is to inhibit the excessive mucin secretion and/or production using agents that have already been clinically used for the management of various diseases. According to a number of studies, ambroxol -one of the clinically-used mucolytics and/or expectorants -was reported to demonstrate anti-oxidative and/or anti-infl ammatory activity (Stetinova et al., 2004; Beeh et al., 2008) . Ambroxol increased the secretion of pulmonary surfactant which is involved in the expectorant action of ambroxol (Miyata et al., 1986) . Ambroxol provoked serous and mucous secretion and restored normal production of mucin in patients suffering from chronic bron-
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Biomol Ther 19(1), 65-69 (2011) (Aliperta et al., 1986) . However, to the best of our knowledge, there are no reports concerning the potential effect of ambroxol on mucin production, gene expression or secretion by airway epithelial cells. Therefore, in this study, we investigated the effect of ambroxol on mucin production and gene expression in NCI-H292 cells, a human pulmonary mucoepidermoid cell line, and also ambroxol's effect on mucin secretion as stimulated by adenosine triphosphate (ATP), from primary cultured rat tracheal surface epithelial (RTSE) cells.
MATERIALS AND METHODS

Materials
All the chemicals and reagents used in this experiment were purchased from Sigma (St. Louis, MO, U.S.A.) unless otherwise specifi ed.
Primary rat tracheal surface epithelial (RTSE) cell culture
Animals were housed and cared for in accordance with the Guide for the Care and Use of Laboratory Animals as regulated by Chungnam National University. Tracheas were obtained from male Sprague Dawley (SD) rats, 5 weeks of age (Harlan Sprague Dawley, Indiana, U.S.A.). RTSE cells were harvested and cultured on a thick collagen gel substratum as previously reported (Wasano et al., 1988; Ko et al., 1999) . Briefl y, animals were euthanized in a CO 2 chamber and the tracheas were exposed under aseptic conditions. The tracheas were cannulated using a polyethylene tube through which the tracheal lumen was fi lled with 0.1% pronase (Type XIV) prepared in Ca ++ , Mg ++ -free Minimum Essential Medium (MEM, GIBCO-BRL, U.S.A.) and incubated at 4 o C for 16 h. The luminal contents were fl ushed, and cells were washed twice with Ca ++ , Mg ++ -free Minimum Essential Medium containing 10% fetal bovine serum by centrifugation at 200×g. The washed cell pellets were dissociated in a growth medium containing Medium 199 and Dulbecco's Modifi ed Eagle's medium (DME) (1:1) supplemented with insulin (5 μg/ml), epidermal growth factor (12.5 ng/ml), hydrocortisone (0.1 μM), fetal bovine serum (5% v/v, Hyclone, Logan, UT, U.S.A.), sodium selenite (0.01 μM), retinoic acid (0.1 μM), Penicillin G (100 U/ml, GIBCO-BRL), Streptomycin (100 μg/ml, GIBCO-BRL) and Gentamicin (50 μg/ml) ("complete" medium). At this stage, most of the cells were in small aggregates and were plated at a density of 10 4 cells/cm 2 into tissue culture dishes containing a thick collagen gel (0.15 ml/cm 2 ) using collagen type I (Regenmed, Seoul, Korea). Cultures were incubated at 37 o C in a humidifi ed atmosphere containing 95% air and 5% CO 2 and culture medium was changed on days 1, 3, 5 and 7.
Treatment of RTSE cells with ambroxol and quantitation of mucins by ELISA
Confl uent RTSE cells were prepared according to the aforementioned method. On culture day 6, spent medium from each culture well was removed and 200 μl of fresh complete medium was added to each well. Following a 24 h incubation, the spent media (designated as the pretreatment (PT) sample) was collected and the cultures were washed twice with Dulbecco's phosphate-buffered saline (PBS) without Ca ++ and Mg ++ before chasing for 30min in PBS containing varying concentrations of ambroxol (the treatment (T) sample).
Ambroxol hydrochloride and ATP were dissolved in doubledistilled, deionized water (DDW) and administered in PBS. The fi nal pH values of these solutions were between 7.0 and 7.4. PBS solution in this range did not affect mucin secretion by RTSE cells. Floating cells and cell debris were removed by centrifugation of samples at 12,000×g for 5 min. The samples were stored at −70 o C until assayed for their mucin contents. The amount of mucins in each sample was measured by using enzyme-linked immunosorbent assay (ELISA). PT and T samples were diluted with PBS at 1:10 ratio and 100 μl of each sample was incubated at room temperature in a 96-well plate for 2 h. Wells were washed three times with PBS and blocked with 2% BSA for 1 h at room temperature. Wells were again washed three times with PBS and then incubated with 100 μl of 17Q2 (Covance, U.S.A.), a mouse monoclonal anti-total mucin antibody, which was diluted with PBS containing 0.05% Tween 20 (1:1,000), and dispensed into each well. After 1h, wells were washed three times with PBS, and 100 μl of horseradish peroxidase-goat anti-mouse IgG conjugate (1:3,000) was dispensed into each well. After 1 h, wells were washed three times with PBS. Color reaction was developed with 3,3',5,5'-tetramethylbenzidine (TMB) peroxide solution and stopped with 1N H 2 SO 4 . Absorbance was read at 450 nm. The effect of ambroxol on mucin secretion was measured as follows: the amount of mucin secreted during the treatment period was divided by the amount of mucin secreted during the pretreatment period and the ratio was expressed as a secretory index. Means of secretory indices from each group were compared and the differences were assessed using statistics.
NCI-H292 cell culture
NCI-H292 cells, a human pulmonary mucoepidermoid carcinoma cell line, were purchased from the American Type Culture Collection (ATCC, Manassas, VA, U.S.A.) and cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS) in the presence of penicillin (100 units/ml), streptomycin (100 μg/ml) and HEPES (25 mM) at 37 o C in a humidifi ed, 5% CO 2 / 95% air, water-jacketed incubator. For serum deprivation, confl uent cells were washed twice with phosphate-buffered saline (PBS) and re-cultured in RPMI 1,640 containing 0.2% fetal bovine serum for 24 h.
Treatment of cells with ambroxol
Following 24 h of serum deprivation, cells were pretreated with ambroxol (1, 10 and 100 μM) for 30 min and then treated with EGF (25 ng/ml) or PMA (10 ng/ml) for 24 h in serumfree RPMI 1640. After 24 h, cells were lysed with buffer solution containing 20 mM Tris, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA and protease inhibitor cocktail (Roche Diagnostics, IN, U.S.A.) and collected to measure the production of MUC5AC protein (in 24-well culture plate). The total RNA was extracted for measuring the expression of MUC5AC gene (in 6-well culture plate) by using RT-PCR.
MUC5AC mucin analysis using ELISA
MUC5AC protein was measured by using ELISA. Cell lysates were prepared with PBS at 1:10 dilution, and 100 μl of each sample was incubated at 42 o C in a 96-well plate, until dry. Plates were washed three times with PBS and blocked with 2% BSA (fraction V) for 1 h at room temperature. Plates were again washed three times with PBS and then incubated with 100 μl of 45M1, a mouse monoclonal MUC5AC antibody
